U-Blot® Research Grade IPH4301Cat. No. WA3004$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade IPH4301Cat. No. WA3004
U-Blot® Research Grade IparomlimabCat. No. WA3003
U-Blot® Research Grade IpafriceptCat. No. WA3002
U-Blot® Research Grade IO-202Cat. No. WA3001
U-Blot® Research Grade IO-108Cat. No. WA3000
U-Blot® Research Grade invobenitugCat. No. WA2999
U-Blot® Research Grade Invikafusp AlfaCat. No. WA2998
U-Blot® Research Grade IntetumumabCat. No. WA2997
U-Blot® Research Grade Insulin LisproCat. No. WA2996
U-Blot® Research Grade Insulin GlargineCat. No. WA2995
U-Blot® Research Grade insulin eflivetCat. No. WA2994
U-Blot® Research Grade Insulin DegludecCat. No. WA2993